Frias JP, Choi J, Rosenstock J, Popescu L, et al. Efficacy and Safety of Once-Weekly Efpeglenatide Monotherapy Versus Placebo in Type 2 Diabetes: The AMPLITUDE-M Randomized Controlled Trial. Diabetes Care 2022 Jun 7. pii: 147061. doi: 10.2337/dc21-2656.
PMID: 35671039